OPEN Health and fusion announce partnership to deliver AI-powered healthcare communications

London, June 24, 2024 (GLOBE NEWSWIRE) — June 24, 2024, London, UK – OPEN Health, a pre-eminent global provider of scientific communicationsHEOR and market accesspatient engagement, and consulting, today announced a partnership with fusion, an innovative artificial intelligence (AI) and machine learning (ML) solutions provider that will work exclusively with OPEN Health. This alliance will see fusion’s market-leading AI capabilities deployed across OPEN Health’s extensive global client base, which includes 49 of the top 50 pharmaceutical companies.

Mary McGregor, Founder of fusion, commented, “OPEN Health provides an unrivalled platform to expand the AI agenda globally in our sector. Our longstanding relationship with OPEN Health leadership facilitated early conversations, enabling us to quickly market-test joint solutions, which led to a swift and unanimous decision to formalize this collaboration. This partnership empowers us to redefine the boundaries of what AI can accomplish in healthcare.”

Margot Hannah,  Chief Executive Officer of Scientific Communications at OPEN Health, expressed her enthusiasm for the partnership: “We immediately recognized the need to expand our capabilities and started a dialog with fusion about an exclusive partnership to provide pioneering solutions that integrate OPEN Health’s capabilities with fusion’s cutting-edge expertise in AI and ML. Fusion’s expertise in this area is unparalleled, and we are excited about the possibilities this partnership brings for our clients.”

Steve Duryee, Chief Operating and Transformation Officer at OPEN Health, added, “We are committed to harnessing the power of cutting-edge technologies, including AI, ML, robotic process automation, and data analytics, to drive higher value and improved outcomes for our clients. With the recent launch of our Solutions Innovation Center, and the addition of fusion to our extended team of elite-level technology partners, we are now in the pole position to deliver the most innovative, technologically advanced solutions to our biopharmaceutical partners.”

By integrating with fusion’s advanced technology, OPEN Health underscores its commitment to leading the AI agenda with socially beneficial innovations to drive innovation and efficiency for clients. Contact OPEN Health to set up an interactive demonstration at www.openhealthgroup.com/contact-us.

About OPEN Health
OPEN Health unites world-class scientific, strategic, and creative expertise to solve complex challenges for global biopharma. We are a flexible, global organization, creating high-performing strategic partnerships with our clients. We embrace our different perspectives and strengths to deliver innovative solutions that have a positive impact on commercial and patient outcomes. OPEN Health unlocks possibilities across consulting, HEOR and market access, scientific communications, and patient engagement. To learn more, visit www.openhealthgroup.com.

About fusion
fusion specializes in delivering AI and ML solutions. Known for its advanced technology and innovative approach, fusion aims to transform the pharmaceutical industry by integrating AI-first solutions. To learn more, visit www.fusionagency.solutions.

Attachment

Candice Subero
OPEN Health
candicesubero@openhealthgroup.com

GlobeNewswire Distribution ID 9157597

Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic EXBLIFEP® in Gulf Cooperation Council countries and South Africa

Acino gains commercial rights for EXBLIFEP® (cefepime/enmetazobactam) within the member states of the Gulf Cooperation Council (GCC) and South Africa. EXBLIFEP® has been approved by the U.S. Food and Drug Administration (FDA) and the European Commission (EC) for the treatment of severe infections earlier in 2024.

Saint-Louis, France and Weil am Rhein, Germany and Zurich, Switzerland, June 24, 2024 (GLOBE NEWSWIRE) — Allecra Therapeutics (“Allecra”) and Acino today announced the signing of an exclusive licensing agreement under which Acino gains the rights to commercialise Allecra’s antibiotic drug EXBLIFEP® (cefepime/enmetazobactam) within the Republic of South Africa and the member states of the GCC alliance, which includes Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates, effective from 12 June 2024. In addition, the companies have signed a supply agreement under which Allecra will supply the cefepime/enmetazobactam finished product in the above territories.

“Acino has established itself as a leader in South Africa and the GCC region. They are an ideal partner to support us as we build towards commercialisation of EXBLIFEP® following our regulatory approvals in the US and EU,” stated Andreas Kranzusch, Chief Financial Officer and Managing Director at Allecra Therapeutics. “This agreement reflects the understanding that there remains a significant global need to address the dangerous increase of resistance to standard-of-care antibiotics, and we look forward to working with Acino to address this.”

“At Acino, we are dedicated to providing novel healthcare solutions to physicians and patients, aiming to alleviate the health burden in emerging markets. We are incredibly excited to partner with Allecra to offer access to this innovative product in two key geographic regions and, potentially, beyond,” said Andrew Bird, CEO (ai) at Acino. “We are committed to expediting the registration process in these designated markets to ensure hospitals’ swift access to EXBLIFEP® as they continue to fight against high-risk infectious diseases in patients.”

About EXBLIFEP® (cefepime/enmetazobactam)

EXBLIFEP® is an intravenous antibiotic fixed-dose combination of enmetazobactam, a novel extended-spectrum β-lactamase inhibitor belonging to the penicillanic acid sulfone class, with the fourth-generation cephalosporin cefepime. Enmetazobactam has been shown to restore the efficacy of cefepime against some multi-drug resistant bacteria, including ESBL-producing pathogens alone or in combination with some resistant β-lactamase mutations as OXA-48 or AmpC, which are increasing in Europe and for which there are few therapeutic alternatives.

EXBLIFEP® demonstrated statistically significant superior overall treatment success in Allecra’s pivotal Phase III ALLIUM trial, which compared 1034 randomized patients receiving either cefepime 2 g/enmetazobactam 0.5 g or piperacillin 4 g/tazobactam 0.5 g every 8 h as 2 h continuous intravenous infusion in a multi-centre, randomized, controlled, double-blind, global study in 112 sites within nineteen countries.

In February 2024, the U.S. Food and Drug Administration (FDA) approved EXBLIFEP® as a treatment for complicated urinary tract infections (cUTI), including pyelonephritis, in patients 18 years and older. In March 2024 the European Commission (EC) granted marketing authorisation for EXBLIFEP® for the treatment of adult patients with cUTI, including pyelonephritis; hospital-acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP); and bacteraemia that occurs in association with, or is suspected to be associated with any of the infections listed previously.

About Allecra Therapeutics

Allecra Therapeutics, founded in 2013, is a private, clinical-stage biopharmaceutical company developing novel therapies to combat antibiotic resistance by overcoming emergent resistance mechanisms. Lead product candidate EXBLIFEP® (cefepime/enmetazobactam), has successfully completed a randomized, controlled, double-blind, global Phase 3 trial compared to standard of care in patients with complicated urinary tract infections (cUTIs). Based on these results, the company has received FDA marketing approval in the U.S. and announced approval in the European Union for EXBLIFEP® earlier this year.

Allecra has significant patent protection covering proprietary enmetazobactam in major territories. Allecra’s investors include Forbion, Andera Partners, Delos Capital, Xeraya Capital, EMBL Ventures, and BioMedPartners. Allecra’s wholly owned French subsidiary is a beneficiary of financial support from Bpifrance and the Région Alsace. Please visit www.allecra.com for further information.

About Acino

Acino is a Swiss pharmaceutical company headquartered in Zurich with a clear focus on selected markets in the Middle East, Africa, Ukraine, the CIS Region, and Latin America. We deliver quality pharmaceuticals to promote affordable healthcare in these emerging markets and leverage our high-quality pharmaceutical manufacturing capabilities and network to supply leading companies through contract manufacturing and out-licensing. For more information, please visit www.acino.swiss.

Acino is part of Arcera, a global company in the life sciences sector headquartered in Abu Dhabi, United Arab Emirates. Arcera was established by ADQ, an Abu Dhabi-based investment and holding company, to build a global life sciences powerhouse poised to make significant contributions to realising the UAE’s aspiration to emerge as a frontrunner in science and technology. To learn more about Arcera, please visit www.arceralifesciences.com.

Attachments

For Allecra Therapeutics:
Andreas Kranzusch, Chief Financial Officer and Managing Director
ir@allecra.com

Gretchen Schweitzer, Trophic Communications, +49 172 8618540
allecra@trophic.eu

For Acino: 
Larisa Bernstein, Global Head of Communications
larisa.bernstein@acino.swiss

GlobeNewswire Distribution ID 9157528

Over N.dollar 400 000 raised at Eenhana Gala Dinner


An amount of N.dollars 414 470 was raised at a gala dinner held on Saturday ahead of the Eenhana Annual Trade and Business Expo in Eenhana.

The 14th edition of the Eenhana Trade and Business Expo is being held under the theme; ‘Reviving Local Economy Through Business Resilience, Innovation and Diversification.’

The expo will run from 29 July to 04 August 2024.

Speaking at the gala dinner, Minister of Finance, Iipumbu Shiimi said business people should play their part because development is a partnership between the public and private sectors, and without entrepreneurship, one will not be able to develop a country or region as they need the business sector.

According to Shiimi, developing the country is hard but possible, as countries that have attained what is called an industrialised status have taken more than 100 years to reach that state.

‘Government’s role is to ensure that key infrastructure is in place, such as roads and water infrastructure, so that development can take place,’ he said.

Shiimi
further indicated that they now need to start thinking about how to generate income in this economy by building on basic skills to grow the region’s economy.

Speaking at the same occasion, Eenhana Mayor, Omri-Onn Kavandje indicated that they are reinventing the theme of last year’s expo in a process that requires collaboration.

‘The significance of this theme lies in business survival amid unforeseen situations and any disasters that might hit any sector locally and regionally. By embracing innovation and introducing more products and service lines, this will complement the efforts to ensure the survival of businesses, which are the backbone of the economy of Eenhana town, Ohangwena Region, and Namibia as a whole,’ he said.

Kavandje stressed that events of this magnitude play a crucial role in showcasing their organisation’s culture, values, and brand image.

Source: The Namibia Press Agency

Government remains committed to supporting farmers: Schlettwein


Minister of Agriculture, Water and Land Reform, Calle Schlettwein said government remains steadfast in its commitment to supporting farmers and rural communities.

Schlettwein, in a speech read on his behalf at the launch of the Kadila Poultry Farm in Okahandja on Friday, called on the Meat Board, the Ministry of Industrialization and Trade, and all industry players to ensure there is a robust local market for local production.

‘It is crucial that we prioritise and support Namibian products, fostering a self-sufficient and thriving agricultural sector. Moreover, the jobs created here will provide stable incomes for many families, contributing to the overall economic development of our country,’ he said.

Schlettwein added that Kadila Poultry Farm will increase Namibia’s poultry production capacity, thereby reducing the country’s reliance on imports, keeping more of the wealth within the country’s borders and strengthening the food supply chain.

‘We are not just inaugurating a new poultry farm, we are celebr
ating the spirit of entrepreneurship, innovation, and private sector initiative that drives our nation forward,’ he said.

He said that the project is geared to not only create much-needed employment opportunities, but is also aimed at strengthening Namibia food basket with poultry produce, adding that the agricultural sector has always been the backbone of the Namibia’s economy, providing sustenance, employment and hope to countless Namibian families.

‘Let us remember that Kadila is a symbol of what we can achieve when the private sector and the community work together with a shared purpose, it reminds us that progress is made through collaboration, dedication, and a steadfast belief in our potential,’ he said.

Kadila Poultry Farm is a 100 per cent Namibian-owned broiler producer that will operates a six-house broiler farm with a capacity of producing 400 tons of poultry meat per month and is expected to create over 350 jobs once fully operational.

Source: The Namibia Press Agency

UNAM, ||Kharas Governor’s office provide mushroom cultivation training


The Office of the ||Kharas Governor, in collaboration with the University of Namibia (UNAM) Centre of Research Services, has trained about 13 women in the cultivation of oyster mushrooms between Monday and Friday.



According to Fimanekeni Shivute, a researcher for multidisciplinary research at UNAM, who was also the facilitator of the training, the initiative formed part of the agriculture integrated project that the governor’s office has embarked on, which consists of the cultivation of rice, mushrooms, and vegetables.



‘The project is integrated in a way that the three productions feed each other. First, we start with the cultivation of rice. After the rice harvest, we use the straw of the rice to cultivate mushrooms because mushrooms need a growing substrate, and the rice straw can be the substrate. After we have cultivated the mushrooms, there is something that remains in the bag that is considered waste, which we can then use as compost for the vegetables,’ she said.



The training took place Friday at Farm Goenbult, covering topics such as mushroom cultures, spawn preparation, the mixing and pasteurising substrate, setting up mushroom houses, and watering, among others. At the end of the training, the women mixed the mushroom spawn with the damp straw, which is expected to yield mushrooms within six weeks.



Speaking to Nampa, 35-year-old Emmarentia Fleermuys, who was one of the participants in the training, said, ‘The training really taught us how to cultivate mushrooms in a fast, safe, and cheap way. One can do it anywhere, even at our houses. I also plan to share the information with others so we can do something for ourselves and make a livelihood and change circumstances at home.’



||Kharas Governor, Aletha Frederick, urged for teamwork among stakeholders within the region to ensure that the centre becomes a catalyst for agricultural development, not only in ||Kharas but across Namibia, noting that collective effort can create a future where agriculture is not just a source of livelihood but a catalyst for progress and prosperity.



‘The future of our region, and indeed our nation, lies in the hands of our youth and women. By investing in their agricultural education and empowering them with the skills they need to succeed, we are investing in a brighter, more prosperous future for all,’ she stressed.





Source: The Namibia Press Agency



Nujoma remembers late sister as pillar of strength


Founding President, Dr Sam Nujoma, said his late sister, Frieda Nandjala Daniel, was their pillar of strength and a fountain of wisdom.

Nujoma made the remarks during Daniel’s funeral at Oneeke Cemetery at Etunda in the Omusati Region on Saturday.

Nujoma said that he affectionately called her Nandjala gwaNdani Shilandula Shandje, a name which he will never forget.

‘She was a force to be reckoned with and who would know that better than me as she follows me? She had a strong voice, an aura that you cannot ignore,’ he said.

He added that although life threw some curveballs. her way, Daniel always seemed up to the task of meeting those challenges.

Nujoma said his sister was always a fighter and that as a result, they had every confidence that she would soundly defeat the illness that had threatened her.

Moreover, he noted that they knew that she had so much more to give, to teach, to share with her children, grandchildren and the entire family.

‘As I stand here before you all today, looking out at the man
y lives she touched, I know that she has achieved what she set out to and she will always be remembered for her warmth and generosity, as well as for her unflagging optimism, and her great big motherly and grandmother’s heart,’ he added.

Nujoma stressed that his sister had set an example of courage and compassion that inspired everyone who knew her.

Source: The Namibia Press Agency

Man allegedly commits suicide by hanging at Otavi


A 28-year-old man allegedly committed suicide by hanging inside his sleeping room at Farm Klein Otavi in the Otjozondjupa Region on Saturday evening.

Namibian Police Force (NamPol) head of community affairs in the region, Senior Inspector Maureen Mbeha, in a media statement issued to Nampa on Sunday said the deceased was identified by his close relatives the same night as Gert Alwayn van der Linden.

‘The deceased allegedly used a rope to hang himself around his neck against the ceiling roof of his sleeping room on Saturday night at 21h00,’ Mbeha said.

No suicide note was found and no foul play is suspected.

In a separate incident, a 31-year-old man, identified as Robert Tsibeb, was found in the bushes of Extension Nine residential area at Grootfontein in the early hours of Saturday morning.

According to Mbeha, the body was discovered lying in a pool of blood, with multiple head injuries.

‘It is suspected Tsibeb might have been attacked by unknown suspects,’ said Mbeha.

The police officer stated that Ts
ibeb was found in a non-responsive state at 03h00 and he was then taken to the Grootfontein State Hospital, where he died while receiving medical treatment.

Hi next of kin have been informed of his death, said Mbeha.

No arrest has been made in connection with the incident and police investigations continue.

Source: The Namibia Press Agency

Man allegedly commits suicide by hanging at Otavi


A 28-year-old man allegedly committed suicide by hanging inside his sleeping room at Farm Klein Otavi in the Otjozondjupa Region on Saturday evening.

Namibian Police Force (NamPol) head of community affairs in the region, Senior Inspector Maureen Mbeha, in a media statement issued to Nampa on Sunday said the deceased was identified by his close relatives the same night as Gert Alwayn van der Linden.

‘The deceased allegedly used a rope to hang himself around his neck against the ceiling roof of his sleeping room on Saturday night at 21h00,’ Mbeha said.

No suicide note was found and no foul play is suspected.

In a separate incident, a 31-year-old man, identified as Robert Tsibeb, was found in the bushes of Extension Nine residential area at Grootfontein in the early hours of Saturday morning.

According to Mbeha, the body was discovered lying in a pool of blood, with multiple head injuries.

‘It is suspected Tsibeb might have been attacked by unknown suspects,’ said Mbeha.

The police officer stated that Ts
ibeb was found in a non-responsive state at 03h00 and he was then taken to the Grootfontein State Hospital, where he died while receiving medical treatment.

Hi next of kin have been informed of his death, said Mbeha.

No arrest has been made in connection with the incident and police investigations continue.

Source: The Namibia Press Agency